In the in vivo and in vitro experiments, FTO/E2F1/NELL2 axis was proposed to be responsible for augmenting NSCLC cell migration, invasion, and metastasis (Wang et al., 2021b). The gene discussed is FTO; the disease is non-small cell lung carcinoma.